Medicare Reverses Course On Decision To Universally Cover Breakthrough Medical Devices For 4 Years

In January the Centers for Medicare and Medicaid Services (CMS) finalized a rule on coverage of breakthrough medical devices that would allow for coverage for four years. Last month, CMS reversed course, by proposing to rescind the rule due primarily to clinical evidence concerns.

Source: Forbes.com Healthcare News - October 4, 2021 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news